{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:33:58Z","timestamp":1789450438006,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.tips.2021.01.002","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T02:19:13Z","timestamp":1611368353000},"page":"217-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Identifying New Antimigraine Targets: Lessons from Molecular Biology"],"prefix":"10.1016","volume":"42","author":[{"given":"Lars","family":"Edvinsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian Agmund","family":"Haanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2021.01.002_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The International Classification of Headache Disorders, 3rd edn","volume":"38","author":"Headache Classification Committee of the International Headache Society","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2021.01.002_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s10194-018-0846-2","article-title":"Migraine is first cause of disability in under 50s: will health politicians now take notice?","volume":"19","author":"Steiner","year":"2018","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/head.13300","article-title":"A phase-by-phase review of migraine pathophysiology","volume":"58","author":"Dodick","year":"2018","journal-title":"Headache"},{"key":"10.1016\/j.tips.2021.01.002_bb0025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrneurol.2017.137","article-title":"Human models of migraine - short-term pain for long-term gain","volume":"13","author":"Ashina","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tips.2021.01.002_bb0030","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1526-4610.2011.01892.x","article-title":"One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010","volume":"51","author":"Tfelt-Hansen","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.tips.2021.01.002_bb0035","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/brain\/aww097","article-title":"The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks","volume":"139","author":"Schulte","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.tips.2021.01.002_bb0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/0333102420911623","article-title":"Altered regional cerebral blood flow and hypothalamic connectivity immediately prior to a migraine headache","volume":"40","author":"Meylakh","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2014.11.031","article-title":"Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier","volume":"1600","author":"Eftekhari","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2021.01.002_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10194-015-0575-8","article-title":"Experimental inflammation following dural application of complete Freund\u2019s adjuvant or inflammatory soup does not alter brain and trigeminal microvascular passage","volume":"16","author":"Lundblad","year":"2015","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0333102419896760","article-title":"Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier","volume":"40","author":"Noseda","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s10194-020-01134-1","article-title":"The fifth cranial nerve in headaches","volume":"21","author":"Edvinsson","year":"2020","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0065","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.64.10_suppl_2.S9","article-title":"Migraine as an inflammatory disorder","volume":"64","author":"Waeber","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2021.01.002_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11916-009-0040-y","article-title":"Migraine pain, meningeal inflammation, and mast cells","volume":"13","author":"Levy","year":"2009","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.tips.2021.01.002_bb0075","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41582-019-0216-y","article-title":"Does inflammation have a role in migraine?","volume":"15","author":"Edvinsson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tips.2021.01.002_bb0080","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1523\/JNEUROSCI.0232-19.2019","article-title":"CSD-induced arterial dilatation and plasma protein extravasation are unaffected by fremanezumab: implications for CGRP\u2019s role in migraine with aura","volume":"39","author":"Schain","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.01.002_bb0085","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jpain.2013.03.010","article-title":"Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system","volume":"14","author":"Eftekhari","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0166-2236(85)90050-5","article-title":"Functional-role of perivascular peptides in the control of cerebral-circulation","volume":"8","author":"Edvinsson","year":"1985","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2021.01.002_bb0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410330109","article-title":"The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats","volume":"33","author":"Goadsby","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2021.01.002_bb0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/brain\/117.3.427","article-title":"Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies","volume":"117","author":"Goadsby","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.tips.2021.01.002_bb0105","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies - successful translation from bench to clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tips.2021.01.002_bb0110","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuroscience.2010.05.016","article-title":"Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion","volume":"169","author":"Eftekhari","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2021.01.002_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/bcp.12618","article-title":"CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment","volume":"80","author":"Edvinsson","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2021.01.002_bb0120","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/0333102411398152","article-title":"Tracing neural connections to pain pathways with relevance to primary headaches","volume":"31","author":"Edvinsson","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0125","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cne.23828","article-title":"Localization of CGRP receptor components and receptor binding sites in rhesus monkey brainstem: A detailed study using in situ hybridization, immunofluorescence, and autoradiography","volume":"524","author":"Eftekhari","year":"2016","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.tips.2021.01.002_bb0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/head.13077","article-title":"Amylin","volume":"57","author":"Hay","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.tips.2021.01.002_bb0135","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/bph.12129","article-title":"CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?","volume":"170","author":"Walker","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2021.01.002_bb0140","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3389\/fphar.2020.01240","article-title":"Antagonism of CGRP signaling by rimegepant at two receptors","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tips.2021.01.002_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.lfs.2006.01.003","article-title":"Characterisation of CGRP receptors in the human isolated middle meningeal artery","volume":"79","author":"Gupta","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.tips.2021.01.002_bb0150","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1526-4610.2007.00854.x","article-title":"Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology","volume":"47","author":"Thalakoti","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.tips.2021.01.002_bb0155","doi-asserted-by":"crossref","first-page":"10587","DOI":"10.1523\/JNEUROSCI.2211-17.2017","article-title":"Fremanezumab-A humanized monoclonal anti-CGRP antibody-inhibits thinly myelinated (Adelta) but not unmyelinated (C) meningeal nociceptors","volume":"37","author":"Melo-Carrillo","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.01.002_bb0160","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1177\/0333102413483931","article-title":"Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients","volume":"33","author":"Tuka","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0165","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/acn3.113","article-title":"Pituitary adenylate cyclase activating polypeptide and migraine","volume":"1","author":"Zagami","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.tips.2021.01.002_bb0170","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/brain\/awt369","article-title":"Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38","volume":"137","author":"Amin","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.tips.2021.01.002_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0333102419864507","article-title":"PACAP27 induces migraine-like attacks in migraine patients","volume":"40","author":"Ghanizada","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0180","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-2982.2007.01497.x","article-title":"Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine","volume":"28","author":"Rahmann","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0185","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2021.01.002_bb0190","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1177\/0333102420937655","article-title":"Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers","volume":"40","author":"Pellesi","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0195","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1177\/0333102420929026","article-title":"Differences in pituitary adenylate cyclase-activating peptide and calcitonin gene-related peptide release in the trigeminovascular system","volume":"40","author":"Edvinsson","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0333102420970889","article-title":"A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention","volume":"41","author":"Ashina","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1124\/jpet.118.253443","article-title":"Pharmacologic characterization of ALD1910, a potent humanized monoclonal antibody against the pituitary adenylate cyclase activating peptide","volume":"369","author":"Moldovan","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2021.01.002_bb0210","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fncel.2019.00114","article-title":"PACAP-38 and PACAP(6-38) degranulate rat meningeal mast cells via the orphan MrgB3-receptor","volume":"13","author":"Pedersen","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tips.2021.01.002_bb0215","first-page":"394","article-title":"Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90","volume":"34","author":"Goadsby","year":"1994","journal-title":"Headache"},{"key":"10.1016\/j.tips.2021.01.002_bb0220","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1526-4610.2007.00672.x","article-title":"The discovery of a new drug class for the acute treatment of migraine","volume":"47","author":"Humphrey","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.tips.2021.01.002_bb0225","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s40263-019-00630-6","article-title":"Pathophysiological mechanisms in migraine and the identification of new therapeutic targets","volume":"33","author":"Haanes","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.tips.2021.01.002_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)08798-X","article-title":"The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor","volume":"41","author":"Adham","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2021.01.002_bb0235","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/00001756-199608120-00023","article-title":"Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord","volume":"7","author":"Arvieu","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.tips.2021.01.002_bb0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s10194-015-0539-z","article-title":"Two TRPV1 receptor antagonists are effective in two different experimental models of migraine","volume":"16","author":"Meents","year":"2015","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0245","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1177\/0333102419851810","article-title":"Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models","volume":"39","author":"Haanes","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0250","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1468-2982.2006.01219.x","article-title":"Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine","volume":"26","author":"Gupta","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0255","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pharmthera.2018.01.005","article-title":"Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?","volume":"186","author":"Rubio-Beltran","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tips.2021.01.002_bb0260","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1111\/bph.14832","article-title":"Characterization of binding, functional activity, and contractile responses of the selective 5-HT1F receptor agonist lasmiditan","volume":"176","author":"Rubio-Beltran","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2021.01.002_bb0265","doi-asserted-by":"crossref","first-page":"e2222","DOI":"10.1212\/WNL.0000000000006641","article-title":"Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study","volume":"91","author":"Kuca","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2021.01.002_bb0270","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/j.pain.0000000000001801","article-title":"Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system","volume":"161","author":"Labastida-Ramirez","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0275","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/j.pain.0000000000000581","article-title":"Gi-protein-coupled 5-HT1B\/D receptor agonist sumatriptan induces type I hyperalgesic priming","volume":"157","author":"Araldi","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0280","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0333102420938655","article-title":"Medication overuse headache: divergent effects of new acute antimigraine drugs","volume":"40","author":"Holland","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0285","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1210\/en.2011-1459","article-title":"Direct interactions between calcitonin-like receptor (CLR) and CGRP-receptor component protein (RCP) regulate CGRP receptor signaling","volume":"153","author":"Egea","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.tips.2021.01.002_bb0290","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.semcdb.2010.10.002","article-title":"Regulation of sodium channel activity by phosphorylation","volume":"22","author":"Scheuer","year":"2011","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.tips.2021.01.002_bb0295","article-title":"Role of intraganglionic transmission in the trigeminovascular pathway","volume":"15","author":"Hurley","year":"2019","journal-title":"Mol. Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0300","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1177\/0333102418786261","article-title":"Current understanding of trigeminal ganglion structure and function in headache","volume":"39","author":"Messlinger","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0305","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s10194-019-1055-3","article-title":"C-fibers may modulate adjacent Adelta-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system","volume":"20","author":"Edvinsson","year":"2019","journal-title":"J. Headache Pain"},{"issue":"2","key":"10.1016\/j.tips.2021.01.002_bb0310","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1093\/brain\/awaa003","article-title":"Hyperpolarization through ATP-sensitive potassium channels; relevance to migraine pathology","volume":"143","author":"Haanes","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.tips.2021.01.002_bb0315","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/0333102417691762","article-title":"CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured","volume":"38","author":"Walker","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0320","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(00)80323-2","article-title":"Clustering sodium channels at the node of Ranvier: close encounters of the axon-glia kind","volume":"18","author":"Salzer","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2021.01.002_bb0325","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00401-014-1305-z","article-title":"The node of Ranvier in CNS pathology","volume":"128","author":"Arancibia-Carcamo","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tips.2021.01.002_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004180050001","article-title":"On the molecular architecture of myelinated fibers","volume":"113","author":"Arroyo","year":"2000","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.tips.2021.01.002_bb0335","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2010.09.004","article-title":"Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans","volume":"1361","author":"Classey","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2021.01.002_bb0340","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.pain.2012.01.005","article-title":"mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system","volume":"153","author":"Amrutkar","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0345","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1523\/JNEUROSCI.19-09-03423.1999","article-title":"Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug","volume":"19","author":"Durham","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.01.002_bb0350","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/120.12.2171","article-title":"Microiontophoretic application of serotonin (5HT)1B\/1D agonists inhibits trigeminal cell firing in the cat","volume":"120","author":"Storer","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.tips.2021.01.002_bb0355","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1900-1","article-title":"The emergence of transcriptional identity in somatosensory neurons","volume":"577","author":"Sharma","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.01.002_bb0360","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.neuron.2019.05.039","article-title":"Deep sequencing of somatosensory neurons reveals molecular determinants of intrinsic physiological properties","volume":"103","author":"Zheng","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2021.01.002_bb0365","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0333102419877834","article-title":"Migraine-associated gene expression in cell types of the central and peripheral nervous system","volume":"40","author":"Vgontzas","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tips.2021.01.002_bb0370","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tips.2021.01.002_bb0375","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jnr.23489","article-title":"GABA and its B-receptor are present at the node of Ranvier in a small population of sensory fibers, implicating a role in myelination","volume":"93","author":"Corell","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tips.2021.01.002_bb0380","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuropharm.2017.05.012","article-title":"GABAB receptors and pain","volume":"136","author":"Malcangio","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2021.01.002_bb0385","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1523\/JNEUROSCI.4720-11.2012","article-title":"Dopaminergic signaling in the cochlea: receptor expression patterns and deletion phenotypes","volume":"32","author":"Maison","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.01.002_bb0390","doi-asserted-by":"crossref","first-page":"796e","DOI":"10.1097\/PRS.0000000000000696","article-title":"Electron microscopic and proteomic comparison of terminal branches of the trigeminal nerve in patients with and without migraine headaches","volume":"134","author":"Guyuron","year":"2014","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.tips.2021.01.002_bb0395","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s10194-020-01126-1","article-title":"Microstructural changes in the trigeminal nerve of patients with episodic migraine assessed using magnetic resonance imaging","volume":"21","author":"Mungoven","year":"2020","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0400","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23329","article-title":"Node of Ranvier length as a potential regulator of myelinated axon conduction speed","volume":"6","author":"Arancibia-Carcamo","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.tips.2021.01.002_bb0405","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0006-8993(89)90046-2","article-title":"Sodium channels in single demyelinated mammalian axons","volume":"483","author":"Shrager","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2021.01.002_bb0410","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/365075a0","article-title":"Heteromultimeric K+ channels in terminal and juxtaparanodal regions of neurons","volume":"365","author":"Wang","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.01.002_bb0415","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.cell.2014.03.064","article-title":"A monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief","volume":"157","author":"Lee","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.01.002_bb0420","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1744-8069-8-82","article-title":"Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn","volume":"8","author":"Black","year":"2012","journal-title":"Mol. Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0425","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1152\/jn.01350.2007","article-title":"Biophysical properties of human Na v1.7 splice variants and their regulation by protein kinase A","volume":"99","author":"Chatelier","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tips.2021.01.002_bb0430","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.pain.2014.05.021","article-title":"Inflammatory and neuropathic pain are rapidly suppressed by peripheral block of hyperpolarisation-activated cyclic nucleotide-gated ion channels","volume":"155","author":"Young","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0435","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42766","article-title":"HCN channel-mediated neuromodulation can control action potential velocity and fidelity in central axons","volume":"8","author":"Byczkowicz","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.tips.2021.01.002_bb0440","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tips.2012.04.004","article-title":"HCN2 ion channels: an emerging role as the pacemakers of pain","volume":"33","author":"Emery","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2021.01.002_bb0445","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1113\/jphysiol.2008.163154","article-title":"Role of the hyperpolarization-activated current Ih in somatosensory neurons","volume":"586","author":"Momin","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.tips.2021.01.002_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079523","article-title":"Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in trigeminal ganglia","volume":"8","author":"Manteniotis","year":"2013","journal-title":"PLoSOne"},{"key":"10.1016\/j.tips.2021.01.002_bb0455","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s10194-020-01197-0","article-title":"Estrogen receptors alpha, beta and GPER in the CNS and trigeminal system - molecular and functional aspects","volume":"21","author":"Warfvinge","year":"2020","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.tips.2021.01.002_bb0460","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1177\/0333102420929027","article-title":"Oxytocin as a regulatory neuropeptide in the trigeminovascular system: Localization, expression and function of oxytocin and oxytocin receptors","volume":"40","author":"Warfvinge","year":"2020","journal-title":"Cephalalgia"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721000055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721000055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:10:35Z","timestamp":1759050635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614721000055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0165614721000055"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2021.01.002","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying New Antimigraine Targets: Lessons from Molecular Biology","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2021.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}